These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7617719)

  • 1. Effects of ibogaine on sensory-motor function, activity, and spatial learning in rats.
    Kesner RP; Jackson-Smith P; Henry C; Amann K
    Pharmacol Biochem Behav; 1995 May; 51(1):103-9. PubMed ID: 7617719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of ibogaine on performance in the 8-arm radial maze.
    Helsley S; Fiorella D; Rabin RA; Winter JC
    Pharmacol Biochem Behav; 1997 Sep; 58(1):37-41. PubMed ID: 9264067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ibogaine-like effects of noribogaine in rats.
    Glick SD; Pearl SM; Cai J; Maisonneuve IM
    Brain Res; 1996 Mar; 713(1-2):294-7. PubMed ID: 8725004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for roles of kappa-opioid and NMDA receptors in the mechanism of action of ibogaine.
    Glick SD; Maisonneuve IM; Pearl SM
    Brain Res; 1997 Feb; 749(2):340-3. PubMed ID: 9138735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment with the putative anti-addictive drug, ibogaine, increases the potency of cocaine to elicit locomotor responding: a study with acute and chronic cocaine-treated rats.
    Szumlinski KK; Maisonneuve IM; Glick SD
    Psychopharmacology (Berl); 1999 Jul; 145(2):227-33. PubMed ID: 10463325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ibogaine effects on sweet preference and amphetamine induced locomotion: implications for drug addiction.
    Blackburn JR; Szumlinski KK
    Behav Brain Res; 1997 Dec; 89(1-2):99-106. PubMed ID: 9475618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ibogaine reduces amphetamine-induced locomotor stimulation in C57BL/6By mice, but stimulates locomotor activity in rats.
    Sershen H; Harsing LG; Hashim A; Lajtha A
    Life Sci; 1992; 51(13):1003-11. PubMed ID: 1522749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute and prolonged effects of ibogaine on brain dopamine metabolism and morphine-induced locomotor activity in rats.
    Maisonneuve IM; Rossman KL; Keller RW; Glick SD
    Brain Res; 1992 Mar; 575(1):69-73. PubMed ID: 1504783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex differences in ibogaine antagonism of morphine-induced locomotor activity and in ibogaine brain levels and metabolism.
    Pearl SM; Hough LB; Boyd DL; Glick SD
    Pharmacol Biochem Behav; 1997 Aug; 57(4):809-15. PubMed ID: 9259010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prior morphine exposure enhances ibogaine antagonism of morphine-induced locomotor stimulation.
    Pearl SM; Johnson DW; Glick SD
    Psychopharmacology (Berl); 1995 Oct; 121(4):470-5. PubMed ID: 8619010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ibogaine enhances the expression of locomotor sensitization in rats chronically treated with cocaine.
    Szumlinski KK; Maisonneuve IM; Glick SD
    Pharmacol Biochem Behav; 1999 Jul; 63(3):457-64. PubMed ID: 10418788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negative effects of chronic oral chlorpromazine and olanzapine treatment on the performance of tasks designed to assess spatial learning and working memory in rats.
    Terry AV; Warner SE; Vandenhuerk L; Pillai A; Mahadik SP; Zhang G; Bartlett MG
    Neuroscience; 2008 Oct; 156(4):1005-16. PubMed ID: 18801413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of ibogaine and D-amphetamine: in vivo microdialysis and motor behavior in rats.
    Maisonneuve IM; Keller RW; Glick SD
    Brain Res; 1992 May; 579(1):87-92. PubMed ID: 1623410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ibogaine on naloxone-precipitated withdrawal syndrome in chronic morphine-dependent rats.
    Dzoljic ED; Kaplan CD; Dzoljic MR
    Arch Int Pharmacodyn Ther; 1988; 294():64-70. PubMed ID: 3233054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of ibogaine, and cocaine and morphine after ibogaine, on ventral tegmental dopamine neurons.
    French ED; Dillon K; Ali SF
    Life Sci; 1996; 59(12):PL199-205. PubMed ID: 8809219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects and aftereffects of ibogaine on morphine self-administration in rats.
    Glick SD; Rossman K; Steindorf S; Maisonneuve IM; Carlson JN
    Eur J Pharmacol; 1991 Apr; 195(3):341-5. PubMed ID: 1868880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of ibogaine on local cerebral glucose utilization in drug-naive and morphine-dependent rats.
    Levant B; Pazdernik TL
    Brain Res; 2004 Apr; 1003(1-2):159-67. PubMed ID: 15019575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 18-Methoxycoronaridine, a non-toxic iboga alkaloid congener: effects on morphine and cocaine self-administration and on mesolimbic dopamine release in rats.
    Glick SD; Kuehne ME; Maisonneuve IM; Bandarage UK; Molinari HH
    Brain Res; 1996 May; 719(1-2):29-35. PubMed ID: 8782860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuation of alcohol intake by ibogaine in three strains of alcohol-preferring rats.
    Rezvani AH; Overstreet DH; Lee YW
    Pharmacol Biochem Behav; 1995 Nov; 52(3):615-20. PubMed ID: 8545483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of antiaddictive actions of ibogaine.
    Glick SD; Maisonneuve IS
    Ann N Y Acad Sci; 1998 May; 844():214-26. PubMed ID: 9668680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.